Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma-Reference-Cited by-同舟云学术

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma

Published:2015-12 Issue:1 Volume:15 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Nomdedeu Meritxell,Lara-Castillo María Carmen,Etxabe Amaia,Cornet-Masana Josep María,Pratcorona Marta,Díaz-Beyá Marina,Calvo Xavier,Rozman María,Costa Dolors,Esteve Jordi,Risueño Ruth M.^ORCID

Funder

Ministerio de Economía y Competitividad

Premi Fi de Residència Emili Letang

Fundación Josep Carreras Contra la Leucemia

l’Obra Social “La Caixa”-Fundació Bancària “La Caixa”

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-015-0272-3

Reference20 articles.

1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–7.

2. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315–21.

3. Sison EA, Brown P. The bone marrow microenvironment and leukemia: biology and therapeutic targeting. Expert Rev Hematol. 2011;4(3):271–83.

4. Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood. 2010;115(25):5131–6.

5. Broxmeyer HE, Kohli L, Kim CH, Lee Y, Mantel C, Cooper S, Hangoc G, Shaheen M, Li X, Clapp DW. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol. 2003;73(5):630–8.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor;Hematology;2023-06-06

2. Model-Based Optimal AML Consolidation Treatment;IEEE Transactions on Biomedical Engineering;2020-12

3. Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy;National Science Review;2019-01-22

4. Controversies Regarding Use of Myeloid Growth Factors in Leukemia;Journal of the National Comprehensive Cancer Network;2017-12

5. Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size;BioImpacts;2016-12-29